Navafenterol (AZD8871) in healthy volunteers: safety, tolerability and pharmacokinetics of multiple ascending doses of this novel inhaled, long-acting, dual-pharmacology bronchodilator, in two phase I, randomised, single-blind, placebo-controlled studies.

Victor BalaguerMuna AlbayatyEulalia JimenezUlrika Wählby-HamrénCarol AstburyBeatriz SeoaneMarie-Pierre MaliceAlejhandra LeiAjay AggarwalIoannis Psallidas

Published in: Respiratory research (2020)

ClinicalTrials.gov ; Nos.: NCT02814656 and NCT03159442; URL: www.clinicaltrials.gov .

Keyphrases

placebo controlled
double blind
phase ii
phase iii
study protocol
clinical trial
phase ii study
cystic fibrosis
open label
nitric oxide synthase
case control
pulmonary artery
randomized controlled trial
nitric oxide
aortic dissection
squamous cell carcinoma
pulmonary arterial hypertension
rectal cancer